Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report.

Corrigan, Margaret; Haydon, Geoffrey; Thompson, Fiona; Rajoriya, Neil; Peplow, Claire L; Hubscher, Stefan G; Steven, Neil; Hirschfield, Gideon M; Armstrong, Matthew J

Corrigan, Margaret; Haydon, Geoffrey; Thompson, Fiona; Rajoriya, Neil; Peplow, Claire L; Hubscher, Stefan G; Steven, Neil; Hirschfield, Gideon M; Armstrong, Matthew J.

Afiliação

Corrigan M; National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Birmingham, UK.
Haydon G; The Liver Unit, Queen Elizabeth University Hospitals Birmingham, Birmingham, UK.
Thompson F; The Liver Unit, Queen Elizabeth University Hospitals Birmingham, Birmingham, UK.
Rajoriya N; The Liver Unit, Queen Elizabeth University Hospitals Birmingham, Birmingham, UK.
Peplow CL; The Liver Unit, Queen Elizabeth University Hospitals Birmingham, Birmingham, UK.
Hubscher SG; The Liver Unit, Queen Elizabeth University Hospitals Birmingham, Birmingham, UK.
Steven N; Department of Cellular Pathology, University Hospitals Birmingham, Birmingham, UK.
Hirschfield GM; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Armstrong MJ; National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Birmingham, UK.

JHEP Rep ; 1(1): 66-69, 2019 May.

Article em En | MEDLINE | ID: mdl-32039353

Palavras-chave

Hepatitis; Immunotherapy; Infliximab; checkpoint

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JHEP Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google